Impact of Exigent Research Network’s partnership with the Tempus AI TIME Program on the screening and matching of patients for clinical trials
Gajra, Ajeet, Mallahan, Samantha, Blau, Sibel, Peguero, Julio Antonio, Shoukier, Mahran, Kanaan, Mohamad, Huynh, Chanh Trung, Efiom-Ekaha, Daniel N., Vankayala, Hema M., Kitchen, Kyle, Kendall, Stephan Disean, Orsini, James Michael, Babu, Sunil, Hellyer, Jessica, Weart, Thomas, Meyer, Janelle Marie, Clifford, Christian, Skelly, Danielle, Patnaude, Emily, Cooney, Matthew M.
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
A Case of Relapsed Variant Acute Promyelcytic Leukemia with t(11;17)(q23q21), PLZF/RARa Fusion Gene, with Durable Molecular Remission Following an Induction and Consolidation Regimen That Included ATRA with Low Dose G-CSF and Valproic Acid as a Histone Deacetylase Inhibitor
Get full text
Journal Article